Gå til innholdet
Menu

External collaboration

To nurture innovation across our value chain we work through an extensive global network within the aquaculture business and in close cooperation with various local scientific institutes, authorities, fish farmers and fish health personnel. For us, this is an important contribution to idea creation and the best utilization of resources, yielding a unique basis for development and supply of excellent products to existing and new markets.

We are always open for new partners and proposals to join our way to make aquaculture progress.

External funded R&D projects, ongoing:

Improved vaccines against intracellular pathogens in aquaculture - combining PHARMAQ and Isconova technology
- The project is funded by Eurostars - E!5934 New-Vac.                                                                 

Et flerfaglig prosjekt for å forbedre badebehandling mot lakselus (Topilouse)
- Fiskeri- og havbruksnæringens forskningsfond (FHF) 900466 (2010-2011)

Identifikasjon av ukjente sykdomsagens.
- Norwegian Research council, 200511 (2010-2011).

Indo-Norwegian platform on fish and shellfish vaccine Development.
- Norwegian Research council 183205/S40 Havbruksprogrammet (2008-2011)

A combinatorial mutagenesis approach to improve microbial expression systems.
- Norwegian Research council 182627 (2008-2010).

Intracellular lifestyle of Francisella piscicida in Atlantic cod.
-Norwegian Research council (2010-2013)

External funded R&D projects, closed:

Development of a vaccine for the Korean flat fish aquaculture industry.
- Innovation Norway, IFU 2010

Training in connection with establishment in Vietnam.
- NORAD (2009-2011)

Påvirker avlsarbeidet for økt sjukdomsresistens forekomsten av vaksineskader, immunrespons og effekten av vaksinering?
- Nofima (2007-2010) 

Immunity of Aquatic Animals - IMAQUANIM. 
- 22 partners in Europe, including NVH, NFH and PHARMAQ (2005-2010)

Utvikling av en real time PCR metode for kvantifisering av ILA virus.
- MABIT (2010)

Bilateral cooperation on fish vaccine development for Chinese aquaculture.
- BILAT 190339 (2009)

Heart and Skeletal Muscle Inflammation (HSMI) - molecular characterisation of the virus and vaccine development.
- Fuge 176975 (2006-2009).

Characterisation of Piscirikettsia salmonis, infection and technology development for optimal vaccines against intracellular bacteria. 
- Fuge 180208 (2007-2009).

Vaccines for the catfish (Pangasius sp.) industry in Vietnam.
- IFU project, development of vaccines to the industry in Vietnam (2006-2009).

Characterization of Francisella piscicida infection in Atlantic cod cells.
- MABIT. Two partners, including PHARMAQ (2009)

> Learn more about our value chain

Identify

Samples from diseased fish of a variety of species of different geographical origin are sent directly to our dedicated team of bacteriologists and virologists in R&D for cultivation and characterization. At this stage, the key to success is the joint efforts of our PHARMAQ field force in different regions of the world and cooperation with our external partners including various scientific institutes, fish farmers and fish health personnel.

Cultivation and characterization of virus and bacteria challenge our R&D people. In some cases it even results in identification of previous uncharacterized pathogens.

PHARMAQ actively utilizes IPR actively to secure freedom to operate and to create value and competitive advantages. Several patents and patent applications covering future products and technologies are held by the company.

Research & Development

Identifying the best solutions to our customers' needs for new vaccines and fish health products, requires dedicated and targeted R&D efforts. Effective vaccine solutions to different bacterial and viral diseases depend upon extensive research and development and a broad range of competencies and highly equipped technical facilities.

The causative pathogen for a disease is usually already known before we start development of new vaccine component. Challenges lies in the ability to identify and characterize the best protective antigens, how to produce them and to optimize the way in which the antigens are presented to the fish in order to obtain protection against disease.

The rate of success of introducing new products and development of efficient processes is founded on the firm commitment to re-invest in R&D and related competencies in the PHARMAQ value chain.

Documentation and registration

Documentation requirements for new products are strictly regulated. Through all steps of research, development and product testing the interaction with the PHARMAQ regulatory department is essential in establishing high quality product documentation for different regulatory bodies around the world.

Our vaccines and therapeutics hold veterinary medicinal product licenses in each country in which they are sold. These licenses certify to the quality, safety, efficacy and environmental effects of each product in the local environment.

Production

All PHARMAQ's vaccines are manufactured at our well recognized facility at Overhalla in Norway. Specific diseases in different farmed fish species and regions need separate vaccine and therapeutic solutions. Careful production planning and logistics combined with flexibility, new ideas and core competencies in vaccine manufacturing make this possible.

Quality is documented in every step from preparation of seed material to final product and throughout the product life cycle. Our quality system ensures that the defined product is manufactured and tested the same way every time, securing that the final product meets the requirements regarding quality, safety and efficacy. The final products are released by a Qualified Person (QP), approved by the authorities. As a pharmaceutical company we are frequently inspected by different national regulatory authorities in order to prove our standards.

Customer Service

By providing environmentally sound, safe and efficacious health products and services to our global aquaculture customers, we will continue to meet our main objective namely to be selected by our customers as their preferred supplier and partner. We put pride in being flexible and create customer satisfaction through high quality service and products.

We can only be successful in this effort if our customers produce predictable yields and healthy profits.

PHARMAQs Pharmacovigilance system is an integral part of post marketing activities in the field of veterinary medicinal products.

Did you know...

We allocate around 18% of our revenue to research and development to provide environmentally sound, safe and efficacious products for the aquaculture industry.

Norway

Head office
Production facility
PHARMAQ AS
Skogmo Industriområde
Industrivegen 50
7863 Overhalla, Norway
Tel:+47 74 28 08 00
Fax:+47 74 28 08 01

Oslo office
PHARMAQ AS
Harbitzalléen 2A, 0275 Oslo,
P.O.Box 267 Skøyen, N-0213 Oslo, Norway
Tel: +47 23 29 85 00
Fax: :+47 23 29 85 01
customer.service​@pharmaq.no

Chile

PHARMAQ AS Chile Ltda.
Anibal Pinto # 200, oficina 61,
Puerto Montt, Chile
Tel: +56 65 248 3091
customer.service​@pharmaq.no

United Kingdom

PHARMAQ Ltd.
Unit 15 Sandleheath Industrial Estate,
Fordingbridge,
Hampshire SP6 1PA,
United Kingdom
Tel: +44 1425 656081
Fax: +44-1425 657992
orders@pharmaq.no

Terms & Conditions of Purchase
Terms & Conditions of Sale

Turkey

PHARMAQ Veteriner Ecza Deposu ve Su Ürünleri Tic.Ltd.Şti
KARACAOGLAN MAH. 6166 SK. 21 A BORNOVA/ IZMIR Turkiye
Tel: +90 232 422 23 10
Fax:+90 232 422 32 27
customer.service​@pharmaq.no

Vietnam

PHARMAQ VIETNAM Co. LTD.
8th Fl. , R. 8.5A, E Town Tower
364 Cong Hoa, W.13, D.Tan Binh
Ho Chi Minh City
Vietnam
Tel : +84 08 3812 2461
Fax : +84 08 3812 2712
customer.service​@pharmaq.no

Panama

PHARMAQ CA Panama Inc.
P.H. Albrook Commercial Park, piso 2,
Oficina 108 Ave. Bella Vista, Ancón
Panamá – Panamá
Phone: +507 3215363
Mob.: +507 6675 1109
customer.service​@pharmaq.no

Spain

PHARMAQ Spain Aqua
Avda de Europa 20B
Parque Empresarial La Moraleja
28108 Alcobendas, Spain
Tel: +34 91 419 19 35
customer.service​@pharmaq.no

Singapore

PHARMAQ
8 Cross Street #17-00, PWC Building,
Singapore 048424, Singapore

Tel.: +6596341980
customer.service​@pharmaq.no

PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The co